Navigation Links
Haemonetics Signs Definitive Agreement to Acquire Pall Corporation's Blood Collection, Filtration and Processing Product Lines For $551 Million
Date:4/29/2012

products accelerates Haemonetics' entry into the whole blood collection market and provides resources to facilitate the development of new products in a competitive and highly regulated market.   

Haemonetics will continue to advance its ongoing initiatives aimed at delivering a first whole blood automation package over the next several years.  This will include a new donation workflow module in a software suite, a communications tower for "plug and play" ease of use via a new handheld interface, two peripherals to make the system paperless and smart devices with full data integration and wet set consumables.  The commercial risks associated with this initiative are expected to be diminished and its market acceptance facilitated by established customer relationships.

"Pall's advanced technologies in the area of transfusion medicine align perfectly with Haemonetics' vision and strategy. This transaction will combine the diverse resources of two industry pioneers and immediately extend Haemonetics' already comprehensive array of blood management solutions," said Larry Kingsley, President and Chief Executive Officer of Pall Corporation. "At the same time, it will enable Pall to focus on markets and opportunities where we are best positioned for growth."

Under terms of the agreement, $536 million of the purchase price will be paid upon closing.  Haemonetics intends to finance this with $475 million of new borrowings under term loans plus $61 million existing cash on hand.  J.P. Morgan Securities LLC and Citibank, N.A.  are joint lead arrangers and joint bookrunners for the new term loans.  The remaining $15 million will be payable upon Pall Corporation's replication and delivery of certain manufacturing assets of the filter media business to Haemonetics by 2016.  Until that time, Pall will manage these media assets under a supply agreement.

The purchase price equates to approximately 8 times
'/>"/>

SOURCE Haemonetics Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC
2. Dave Helsel Joins Haemonetics as Vice President of Global Manufacturing
3. Haemonetics Reports 8% Revenue Growth for Second Quarter of Fiscal 2012, Adjusted Earnings Per Share of $0.72 and Updates Previously Provided Full Year Earnings Guidance
4. Haemonetics Sets Date for Second Quarter Fiscal Year 2012 Earnings Release: October 31, 2011
5. Haemonetics Sets Date for Fourth Quarter Fiscal Year 2011 Earnings Release: May 2, 2011
6. Haemonetics to Present at J.P. Morgan Healthcare Conference
7. Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers
8. VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
9. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
10. AtheroNova Signs Agreement for Development of Clinical Trial Supplies
11. HealthyWomen Asks: Do You Know the Signs and Symptoms of von Willebrand Disease (VWD)?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013 /PRNewswire-iReach/ -- In its first major ... company dedicated to advancing development of the ... release drug therapies in patient disease populations ... the acquisition of Enzon Pharmaceutical,s PEGylation Linker ... product pipeline. Acquisition of this technology will ...
(Date:6/19/2013)... , June 19, 2013 Pharma ... new infographic summary of the results from an ... third of all respondents stated that CROs would be an ... of respondents will be running 6 or more clinical trials ... the Clinical Trial Supply USA Summit ...
(Date:6/18/2013)... 2013 Valeant Pharmaceuticals International, Inc. (NYSE: ... today that VPII Escrow Corp., a newly formed wholly ... offer of approximately $3.2 billion aggregate principal amount of ... due in 2021 and in 2023, with final tranching ... use the net proceeds from the offering, together with ...
Breaking Medicine Technology:Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4Pharma IQ Presents the Latest Trends in Clinical Trial Supply 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3
... 24 Children,s Mental Focus,Foundation (CMFF), a nonprofit ... that may be linked to children with autism ... currently working with,doctors that have patients afflicted with ... adults cope with behavioral problems,associated with mental disorders ...
... Marketers, who have the,primary responsibility for communicating the ... as top challenges for pharmaceutical,companies when communicating trial ... worry about competitors stealing your,thunder, but also worry ... According to a Best Practices, LLC benchmarking study, ...
Cached Medicine Technology:Children's Mental Focus Foundation Announces a Scientific Breakthrough for Children Who Have Been Diagnosed With Autism, ADD and ADHD 2Children's Mental Focus Foundation Announces a Scientific Breakthrough for Children Who Have Been Diagnosed With Autism, ADD and ADHD 3Clinical Trial Best Practices: Savvy Marketers Plan Ahead with Early Communication Strategies 2
(Date:6/19/2013)... The Cancer Support Community (CSC), an international ... for the whole patient with the launch today of ... This inaugural event, held at the Newseum, will feature ... of Congress members who have made a significant impact ... families currently engaged in the cancer journey. ...
(Date:6/19/2013)... Arem Wellness was developed and is managed ... Ridha Arem, who is determined to help educate the ... Arem Wellness provides a monthly newsletter, a blog, many ... well as an exceptional supplement line uniquely designed by ... role diet and nutrition have not only on ...
(Date:6/19/2013)... to the head; a swift jarring to the body and ... It’s understandable, but what else may follow a concussion injury? ... According to mayoclinic.com , usual symptoms that accompany ... other symptoms may follow, sometimes not for days or weeks ... dizziness, feeling like you’re in a fog, light or noise ...
(Date:6/19/2013)... OR (PRWEB) June 19, 2013 To survive when ... Pilot and Vietnam veteran Captain W.S. “Bud” Orr, the most important ... Speaking to host Sharon Kleyne on the Sharon Kleyne Hour Power ... kit in Vietnam, he always placed extra water ahead of guns ... weight limit on survival kits that pilots could carry on planes ...
(Date:6/19/2013)... CA (PRWEB) June 19, 2013 ... of an Abbreviated New Drug Application (ANDA) for Hydroxyprogesterone ... generic version of Bristol-Myers Squibb’s drug fomerly known as ... to varied inquiries regarding the anticipated approval and market ... product. , Regarding the status of our pending ANDA, ...
Breaking Medicine News(10 mins):Health News:Keeping the Promise of Cancer Care for the Whole Patient 2Health News:Keeping the Promise of Cancer Care for the Whole Patient 3Health News:Arem Wellness Announces a Recipe Contest 2Health News:Arem Wellness Announces a Recipe Contest 3Health News:Concussions Can Lead to Much More Than a Headache, According to MMTR Health Inc. Founder, Terry Moore, Neuromuscular and Cardiovascular Physiologist 2Health News:Vietnam Navy Pilot Reveals to Radio Host Sharon Kleyne That He Carried Extra Water Not a Gun in Survival Kit 2Health News:Current Progress Towards ANDA Approval of Hydroxyprogesterone Caproate Injection, USP 2
... efforts to cut back, , , SATURDAY, April 25 (HealthDay News) ... important lifestyle changes people with heart failure can make, but ... has found. , Researchers asked 116 people with heart ... Though the recommended daily intake of sodium for people with ...
... more potent treatment with fewer side effects , , SATURDAY, ... more direct delivery of cancer drugs to tumors have ... safe, biodegradable polymer, the nanoparticles are chemically engineered to ... most human tumors, and to carry a higher concentration ...
... - Plastic Surgery increased too, with breast implants and ... bank balances and stunning senior celebs are influencing factors.MANCHESTER, ... has been seen by staff at Transform, the UK,s ... Botox Grannies.More and more women over 60 are having ...
... Research , an association of technology analysts, market researchers, and science ... for expanding the pool of associates and tripling of publication schedule ... ... 2009 -- STIX Market Research , an association of technology ...
... a person,s insurance coverage affect their access to quality ... Center, insurance coverage may not only affect a patient,s ... care they receive. Research findings, presented today at the ... a national debate on healthcare reform. , "We ...
... Ill., April 24 World Veterinary Day, April 25, ... farmers. "This year,s theme, ,Veterinarians and Livestock ... partnership, highlights a discipline of veterinary medicine ... said Dr. W. Ron DeHaven, DVM, MBA, Chief Executive ...
Cached Medicine News:Health News:Hidden Salt in Diet Haunts Many With Heart Failure 2Health News:Nanoparticles May Help Attack Cancer More Directly 2Health News:Growth of Plastic Surgery & Botox Grannies in UK 2Health News:Growth of Plastic Surgery & Botox Grannies in UK 3Health News:STIX Market Research Celebrates Ten Years of Technology/Market Analysis, Custom Research, and Niche Publishing; Prepares New Growth Phase 2Health News:STIX Market Research Celebrates Ten Years of Technology/Market Analysis, Custom Research, and Niche Publishing; Prepares New Growth Phase 3Health News:STIX Market Research Celebrates Ten Years of Technology/Market Analysis, Custom Research, and Niche Publishing; Prepares New Growth Phase 4Health News:Does a person's insurance coverage affect their access to quality cancer care? 2Health News:AVMA Celebrates World Veterinary Day 2
The Diagnostic Automation, Inc. (DAI) Measles IgM Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the in vitro determination of IgM antibody to Measles in human serum....
... over 30 years, Digisonics has set ... with the first review station, the ... and the best multi-modality reporting., ,DigiView ... image review workstations, professional reporting choices, ...
... Cortisol is a glucocorticoid produced by ... hormone (ACTH). It is secreted with a ... waking in the morning. Cortisol is often ... of hypertension, stress, AIDS, and in the ...
... IMMULITE 2500 is a high-throughput immunoassay ... ,of the IMMULITE 2000 with the important ... technology ,allows assays to be designed for ... times. ,This allows for critical assays such ...
Medicine Products: